SOPH SOPHiA GENETICS SA IFRS
Services-Computer Processing & Data Preparation · Nasdaq · SEC CIK 1840706 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY18.6%
TTM net income YoY-26.4%
TTM EPS YoY-23.2%
Revenue 3-yr CAGR17.6%
Net income 3-yr CAGR—
Margins
Gross margin67.4%
Operating margin-91.8%
Net margin-102.2%
FCF margin-47.2%
EBITDA margin—
Returns
ROE-110.0%
ROA-49.6%
ROIC (approx.)-207.1%
Asset turnover0.49x
Leverage & solvency
Liabilities / assets71.1%
Debt / equity1.01x
Current ratio1.96x
Interest coverage-15.57x
Cash quality & payout
Operating cash flow / net income0.45x
Accruals ratio-27.1%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $77.27M | $65.17M | $62.37M | $47.56M | $40.45M |
| Cost of revenue | $25.19M | $21.24M | $19.46M | $16.31M | $15.23M |
| Gross profit | $52.08M | $43.94M | $42.91M | $31.25M | $25.22M |
| R&D expense | $34.22M | $34.37M | $36.97M | $35.37M | $26.58M |
| SG&A expense | $52.56M | $46.95M | $53.30M | $55.82M | $41.51M |
| Operating income | -$70.91M | -$66.57M | -$74.83M | -$87.82M | -$71.49M |
| Interest expense | $4.55M | $1.91M | $588,000 | $639,000 | $658,000 |
| Pretax income | -$77.49M | -$61.27M | -$78.50M | -$87.58M | -$73.51M |
| Income tax | $1.51M | $1.22M | $486,000 | -$136,000 | $168,000 |
| Net income | -$79.00M | -$62.49M | -$78.98M | -$87.45M | -$73.67M |
| EPS (basic) | -1.17 | -0.95 | -1.22 | -1.36 | -1.33 |
| EPS (diluted) | -1.17 | -0.95 | -1.22 | -1.36 | -1.33 |
| Weighted avg. shares (diluted) | 67.54M | 66.06M | 64.75M | 64.10M | 55.30M |
| Banking | |||||
| Net interest income | — | — | $3.96M | $685,000 | -$638,000 |
| Balance sheet | |||||
| Cash & equivalents | $70.29M | $80.23M | $123.25M | $161.31M | $192.96M |
| Short-term investments | — | — | $0 | $17.31M | $72.36M |
| Receivables | $15.00M | $7.44M | $13.56M | $6.65M | $6.28M |
| Inventory | $6.35M | $5.87M | $6.48M | $5.16M | $5.73M |
| Current assets | $99.08M | $99.41M | $148.05M | $196.25M | $282.86M |
| PP&E, netmay include right-of-use assets (IFRS) | $5.67M | $5.21M | $7.47M | $7.13M | $4.66M |
| Intangibles | $35.89M | $29.00M | $27.18M | $19.96M | $15.67M |
| Total assets | $163.03M | $155.31M | $206.16M | $243.84M | $320.17M |
| Current liabilities | $50.53M | $26.80M | $35.62M | $26.81M | $28.60M |
| Long-term debt | $47.73M | $13.24M | $0 | — | — |
| Total debt | $47.73M | $13.24M | $0 | — | — |
| Total liabilities | $115.89M | $58.82M | $54.71M | $43.71M | $44.77M |
| Shareholders' equity | $47.15M | $96.49M | $151.44M | $200.13M | $275.40M |
| Net debt | -$22.56M | -$66.99M | -$123.25M | — | — |
| Cash flow statement | |||||
| Operating cash flow | -$35.89M | -$44.52M | -$53.22M | -$70.09M | -$57.94M |
| Capital expenditure | $574,000 | $244,000 | $1.49M | $4.10M | $2.68M |
| Free cash flow | -$36.47M | -$44.76M | -$54.72M | -$74.19M | -$60.62M |
| Investing cash flow | -$8.67M | -$4.75M | $12.97M | $41.97M | -$56.93M |
| Financing cash flow | $30.18M | $9.86M | -$2.82M | -$1.57M | $237.77M |
| Stock-based compensation | $16.20M | $16.49M | $15.24M | $13.61M | $8.51M |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.